– May 1, 2010
May 1, 2010
View Issues
-
Case Management: Acute Promyelocytic Leukemia
A 44-year-old male patient is seen in the emergency room because of intractable nose bleed, hematuria, and ecchymoses all first noted within the past 48 hours. Previously he had been well, without known medical illness, and was taking no prescription drugs. -
Bendamustine for the Treatment of Indolent Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia
Bendamustine was first synthesized in 1963 in East Germany, but its clinical development as an anti-neoplastic agent really began after the fall of the Iron Curtain. -
Transplantation for Older Adults with AML and MDS
AML and MDS are primarily diseases of older adults with poor long-term outcomes. -
Outcomes for Plasma Exchange to Treat TTP
The risk of relapse after effective therapy with plasma exchange for thrombotic thrombocytopenic purpura (TTP) has not been well-characterized. -
Supplement: Health Care Reform Update
Health care clinicians and organizations likely will find that the new health care reform bill's positive features outweigh its drawbacks, experts say. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
Examining the three arms of the ACCORD trial; and FDA Actions: clopidogrel, dexlansoprazole, and tamsulosin.